Valbiotis' IPO

Valbiotis raised a round of funding on June 07, 2017. Investors include Public.

Valbiotis (EPA: ALVAL), founded in 2014, is a biopharmaceutical company that develops a comprehensive solution to chronic metabolic diseases.…

Articles about Valbiotis' IPO: